Concord Drugs (BOM:538965) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Concord Drugs ROE % Adjusted to Book Value?

Concord Drugs's ROE % for the quarter that ended in Dec. 2024 was 2.68%. Concord Drugs's PB Ratio for the quarter that ended in Dec. 2024 was N/A. Concord Drugs's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was N/A.

Concord Drugs ROE % Adjusted to Book Value Historical Data

The historical data trend for Concord Drugs's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Drugs ROE % Adjusted to Book Value Chart

Concord Drugs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

2.88

13.75

6.49

4.05

1.38

Concord Drugs Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	-3.86	-	0.46	-

Competitive Comparison of Concord Drugs's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Concord Drugs's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Concord Drugs's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Concord Drugs's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Concord Drugs's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Concord Drugs ROE % Adjusted to Book Value Calculation

Concord Drugs's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	1.44%	/	1.04
	=	1.38%

Concord Drugs's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	2.68%	/	N/A
	=	N/A

Concord Drugs ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Concord Drugs's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Drugs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Concord Drugs Ltd (BOM:538965) » Definitions » ROE % Adjusted to Book Value

Traded in Other Exchanges

N/A

Address

Survey No. 249, Brahmanapally Village, Hayatnagar Mandal, Ranga Reddy, Hyderabad, TG, IND, 501511

Website

https://www.concorddrugs.in

Concord Drugs Ltd is an India based pharmaceutical company. The principal activity of the company is to manufacture licensed drugs based on the formulations approved. Its product portfolio includes Pharmaceutical Ready to fill Pellets, MUPS ((Multiple Unit Pellets System); Tissue Bio Adhesive; Injectables (Small Volume Parenterals); Capsules; Liquid Orals (Syrups & Suspensions); Dry Syrups (Powder) and Hand Sanitizers.

Concord Drugs Headlines

No Headlines